Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
39.3%
% of PBE's 28 holdings also in BBH
44.0%
% of BBH's 27 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus BBH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.1% | 12.5% | 5.1% |
|
AMGEN INC | 5.0% | 16.1% | 5.0% |
|
REGENERON PHARMACEUTICALS | 4.5% | 5.2% | 4.5% |
|
NATERA INC | 4.7% | 4.5% | 4.5% |
|
BIOGEN IDEC INC | 5.0% | 3.4% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to BBH
|
UNITED THERAPEUTICS CORP | 4.4% |
|
PROTAGONIST THERAPEUTICS, INC. | 3.9% |
|
TG THERAPEUTICS INC | 3.8% |
|
CATALYST PHARMACEUTICAL PART | 3.3% |
|
HALOZYME THERAPEUTICS INC | 3.1% |
|
PTC THERAPEUTICS INC | 3.0% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% |
|
DYNAVAX TECHNOLOGIES CORP | 2.9% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% |
|
EXELIXIS INC | 2.8% |
PBE Underweight Relative to BBH
|
VERTEX PHARMACEUTICALS INC | -11.2% |
|
AMGEN INC | -11.1% |
|
GILEAD SCIENCES INC | -7.4% |
 |
ARGENX SE ADR | -5.1% |
|
IQVIA HOLDINGS INC | -4.4% |
|
ALNYLAM PHARMACEUTICALS INC | -4.4% |
 |
ICON PLC | -3.6% |
|
INTRA-CELLULAR THERAPIES INC | -2.9% |
|
INSMED INC | -2.6% |
 |
BIONTECH SE SPONSORED ADR | -2.4% |